Rivaroxaban for prevention and treatment of venous thromboembolism

被引：9
|
作者：
Chan, Noel C. [1 ,2 ]
Weitz, Jeffrey, I [1 ,2 ]
机构：
[1] McMaster Univ, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada
[2] McMaster Univ, Dept Med, Hamilton, ON, Canada
来源：
FUTURE CARDIOLOGY | 2019年 / 15卷 / 02期
关键词：
nonvitamin K oral antagonist; rivaroxaban; venous thromboembolism; FACTOR-XA INHIBITOR; DIRECT ORAL ANTICOAGULANTS; DEEP-VEIN THROMBOSIS; TOTAL HIP; ORTHOPEDIC-SURGERY; EXTENDED TREATMENT; KNEE REPLACEMENT; REAL-WORLD; ENOXAPARIN; THROMBOPROPHYLAXIS;
D O I：
10.2217/fca-2018-0076
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Until recently, heparins and vitamin K antagonists (VKAs) were the cornerstones for prevention and treatment of venous thromboembolism (VTE). This situation changed with the introduction of the direct oral anticoagulants, which are now replacing low-molecular-weight heparin for thromboprophylaxis after elective hip or knee arthroplasty and VKAs for VTE treatment. Rivaroxaban, an oral factor Xa inhibitor, was the first direct oral anticoagulant licensed for VTE prevention and treatment. This paper provides the rationale for factor Xa as a target for anticoagulants, describes the development of rivaroxaban, reviews its pharmacological profile, discusses the clinical trials with rivaroxaban for VTE prevention and treatment and highlights areas of uncertainty.
引用
收藏
页码：63 / 77
页数：15
相关论文
共 50 条
  • [31] Therapy adherence, safety and efficacy of rivaroxaban in prevention of venous thromboembolism in patients with hip or knee endoprosthesis
    Tomic, Nemanja
    Andic, Vladimir
    Curlik, Dejan
    Ceko, Jovica
    Avdic, Amna Tanovic
    Mehic, Meliha
    Sukalo, Aziz
    Glamoclija, Una
    EUROPEAN JOURNAL OF ORTHOPAEDIC SURGERY AND TRAUMATOLOGY, 2024, 34 (03) : 1435 - 1440
  • [32] Rivaroxaban vs. warfarin for the treatment and prevention of venous thromboembolism: A meta-analysis
    Liu, Zhuang
    Song, Dan
    Wang, Liang
    Wang, Changfeng
    Zhou, Jie
    Sun, Jiali
    Guo, Lei
    FRONTIERS IN SURGERY, 2023, 10
  • [33] Economic Analysis of Rivaroxaban for the Treatment and Long-Term Prevention of Venous Thromboembolism in Portugal
    Santos, Isabel Fonseca
    Pereira, Sonia
    Mcleod, Euan
    Guillermin, Anne-Laure
    Chatzitheofilou, Ismini
    ACTA MEDICA PORTUGUESA, 2014, 27 (05): : 615 - 624
  • [34] Novel oral anticoagulants for the prevention of venous thromboembolism in surgical patients
    Riva, Nicoletta
    Donadini, Marco P.
    Bozzato, Silvia
    Ageno, Walter
    THROMBOSIS RESEARCH, 2013, 131 : S67 - S70
  • [35] Development of rivaroxaban microemulsion-based hydrogel for transdermal treatment and prevention of venous thromboembolism
    Bernardes Araujo, Cristina da Costa
    Simon, Alice
    Honorio, Thiago da Silva
    Cruz da Silva, Silvia Valeria
    Machado Valle, Isabella Mourao
    Rodrigues Pereira da Silva, Luiz Claudio
    Rodrigues, Carlos Rangel
    de Sousa, Valeria Pereira
    Cabral, Lucio Mendes
    Sathler, Plinio Cunha
    do Carmo, Flavia Almada
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2021, 206
  • [36] Rivaroxaban Treatment for Patients With Unprovoked or Provoked Venous Thromboembolism ― Subanalysis of the J'xactly Study ―
    Hisatake, Shinji
    Ikeda, Takanori
    Fukuda, Ikuo
    Nakamura, Mashio
    Yamada, Norikazu
    Takayama, Morimasa
    Maeda, Hideaki
    Yamashita, Takeshi
    Mo, Makoto
    Yamazaki, Tsutomu
    Okumura, Yasuo
    Hirayama, Atsushi
    CIRCULATION REPORTS, 2022, 4 (10) : 490 - 498
  • [37] Efficacy and safety of rivaroxaban compared to enoxaparin in treatment of cancer-associated venous thromboembolism
    Simmons, Benjamin
    Wysokinski, Waldemar
    Saadiq, Rayya A.
    Bott-Kitslaar, Dalene
    Henkin, Stanislav
    Casanegra, Ana
    Lenz, Charles
    Daniels, Paul
    Bjarnason, Haraldur
    Vargas, Emily
    Hodge, David
    Holton, Sara J.
    Cerhan, James R.
    Loprinzi, Charles
    McBane, Robert
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (02) : 136 - 142
  • [38] Management of Venous Thromboembolism in Morbid Obesity With Rivaroxaban or Warfarin
    Weaver, Paige
    Ng, Tsz Hin
    Breeden, Thomas
    Edwin, Stephanie B.
    Haan, Bradley
    Giuliano, Christopher
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (12) : 1315 - 1324
  • [39] Rivaroxaban for the treatment and prevention of thromboembolic disease
    Antoniou, Sotiris
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2015, 67 (08) : 1119 - 1132
  • [40] Rivaroxaban, a new oral anticoagulant for the prevention of venous thromboembolism after elective hip or knee replacement surgery
    Haas, Sylvia
    Kubitza, Dagmar
    Perzborn, Elisabeth
    EJHP PRACTICE, 2010, 16 (05): : 29 - 36
12345